110 related articles for article (PubMed ID: 2533220)
1. Peripheral hemodynamic and humoral effects of oral zofenopril calcium (SQ. 26,991) in patients with congestive heart failure.
Borghi C; Magelli C; Boschi S; Costa FV; Capelli M; Varani E; Magnani B; Ambrosioni E
J Clin Pharmacol; 1989 Dec; 29(12):1077-82. PubMed ID: 2533220
[TBL] [Abstract][Full Text] [Related]
2. A clinical study on the role of the renin-angiotensin-aldosterone system and catecholamines in chronic congestive heart failure.
Nishioka A; Kubo S; Hirota Y; Kawamura K; Takatsu T
Jpn Heart J; 1982 Jul; 23(4):527-44. PubMed ID: 6752473
[TBL] [Abstract][Full Text] [Related]
3. Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure.
Yoshimura M; Yasue H; Tanaka H; Kikuta K; Sumida H; Kato H; Jougasaki M; Nakao K
Br Heart J; 1994 Dec; 72(6):528-33. PubMed ID: 7857734
[TBL] [Abstract][Full Text] [Related]
4. Effects of a new angiotensin-converting enzyme inhibitor, alacepril, on changes in neurohormonal factors and arterial baroreflex sensitivity in patients with congestive heart failure.
Kinugawa T; Kato M; Mori M; Endo A; Kato T; Hamada T; Noguchi N; Omodani H; Osaki S; Ogino K; Miyakoda H; Hisatome I; Shigemasa C
Eur J Clin Pharmacol; 1998 May; 54(3):209-14. PubMed ID: 9681661
[TBL] [Abstract][Full Text] [Related]
5. Effects of captopril on forearm oxygen consumption during dynamic handgrip exercise in patients with congestive heart failure.
Imaizumi T; Takeshita A; Nakamura N; Sakai K; Hirooka Y; Suzuki S; Yoshida M; Nakamura M
Jpn Heart J; 1990 Nov; 31(6):817-28. PubMed ID: 2084278
[TBL] [Abstract][Full Text] [Related]
6. Plasma vasopressin as influenced by acute and chronic blockade of the renin-angiotensin system.
Stanek B; Bruckner U; Silberbauer K
J Hypertens Suppl; 1985 Nov; 3(2):S129-31. PubMed ID: 3003301
[TBL] [Abstract][Full Text] [Related]
7. Peripheral hemodynamic effects of captopril in patients with congestive heart failure.
Nishimura H; Kubo S; Ueyama M; Kubota J; Kawamura K
Am Heart J; 1989 Jan; 117(1):100-5. PubMed ID: 2643280
[TBL] [Abstract][Full Text] [Related]
8. [Hemodynamic and renal effects of synthetic atrial natriuretic factor (alpha-h-ANF) in patients with congestive heart failure].
Fontana F; Guardigli G; Cappelli M; Bernardi P
G Ital Cardiol; 1988 Jul; 18(7):567-77. PubMed ID: 2976692
[TBL] [Abstract][Full Text] [Related]
9. [Captopril and hypertensive cardiopathy : therapeutic effects and hormonal changes].
Palazzuoli V; Mondillo S; Galli M; Kristodhullu S; Faglia S; D'Aprile N; Martorelli T
Cardiologia; 1990 Jun; 35(6):489-93. PubMed ID: 2150343
[TBL] [Abstract][Full Text] [Related]
10. Comparative effects of verapamil and volume overload on atrial natriuretic factors and the renin-angiotensin aldosterone-vasopressin system.
Buckley JW; Hedner T; Masotto C; Posvar E; Negro-Villar A; Cubeddu LX
J Clin Pharmacol; 1992 Dec; 32(12):1120-7. PubMed ID: 1487551
[TBL] [Abstract][Full Text] [Related]
11. Forearm venous distensibility in relation to severity of symptoms and hemodynamic data in patients with congestive heart failure.
Ikenouchi H; Iizuka M; Sato H; Momomura S; Serizawa T; Sugimoto T
Jpn Heart J; 1991 Jan; 32(1):17-34. PubMed ID: 2038122
[TBL] [Abstract][Full Text] [Related]
12. Possible vascular role of increased plasma arginine vasopressin in congestive heart failure.
Nakamura T; Funayama H; Yoshimura A; Tsuruya Y; Saito M; Kawakami M; Ishikawa SE
Int J Cardiol; 2006 Jan; 106(2):191-5. PubMed ID: 16321691
[TBL] [Abstract][Full Text] [Related]
13. Response of plasma vasopressin to ethanol in congestive heart failure.
Goldsmith SR; Dodge D
Am J Cardiol; 1985 May; 55(11):1354-7. PubMed ID: 3993569
[TBL] [Abstract][Full Text] [Related]
14. Renal, haemodynamic and hormonal interactions between atrial natriuretic factor and arginine vasopressin in patients with congestive heart failure.
Nakamura M; Yoshida H; Funakoshi T; Arakawa N; Hiramori K
Clin Sci (Lond); 1992 Apr; 82(4):363-8. PubMed ID: 1315645
[TBL] [Abstract][Full Text] [Related]
15. Intravenous captopril in congestive heart failure.
Ahmad S; Giles TD; Roffidal LE; Haney Y; Given MB; Sander GE
J Clin Pharmacol; 1990 Jul; 30(7):609-14. PubMed ID: 2202753
[TBL] [Abstract][Full Text] [Related]
16. Relation of atrial natriuretic factor to vasoconstrictor hormones and regional blood flow in congestive heart failure.
Hirsch AT; Creager MA; Dzau VJ
Am J Cardiol; 1989 Jan; 63(3):211-6. PubMed ID: 2521270
[TBL] [Abstract][Full Text] [Related]
17. Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure.
Onogawa T; Sakamoto Y; Nakamura S; Nakayama S; Fujiki H; Yamamura Y
Cardiovasc Drugs Ther; 2011 Dec; 25 Suppl 1():S67-76. PubMed ID: 22120095
[TBL] [Abstract][Full Text] [Related]
18. Acute hemodynamic effect of a vascular antagonist of vasopressin in patients with congestive heart failure.
Nicod P; Waeber B; Bussien JP; Goy JJ; Turini G; Nussberger J; Hofbauer KG; Brunner HR
Am J Cardiol; 1985 Apr; 55(8):1043-7. PubMed ID: 3885704
[TBL] [Abstract][Full Text] [Related]
19. Hormonal responses to synthetic atrial natriuretic peptide in patients on regular hemodialysis.
Nakajima S; Suzuki H; Kageyama Y; Takita T; Saruta T
Acta Endocrinol (Copenh); 1988 Oct; 119(2):257-62. PubMed ID: 2972150
[TBL] [Abstract][Full Text] [Related]
20. [Atrial natriuretic factor, catecholamines and the renin-angiotensin system in cardiac insufficiency. Relation to hemodynamic parameters].
Komajda M; Carayon A; Nguyen JP; Maistre G; Drobinski G; Legrand S; Landault C; Legrand JC; Grosgogeat Y
Arch Mal Coeur Vaiss; 1988 Jul; 81(7):845-53. PubMed ID: 2973293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
